Statin therapy and plasma cortisol concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials
Language English Country Netherlands Media print-electronic
Document type Journal Article, Meta-Analysis, Review, Systematic Review
PubMed
26546969
DOI
10.1016/j.phrs.2015.10.013
PII: S1043-6618(15)00256-X
Knihovny.cz E-resources
- Keywords
- Cortisol level, Meta-analysis, Randomized controlled trial, Statin,
- MeSH
- Hydrocortisone blood MeSH
- Humans MeSH
- Randomized Controlled Trials as Topic MeSH
- Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacology therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Meta-Analysis MeSH
- Review MeSH
- Systematic Review MeSH
- Names of Substances
- Hydrocortisone MeSH
- Hydroxymethylglutaryl-CoA Reductase Inhibitors MeSH
This study aimed to perform a systematic review and meta-analysis of randomized controlled trials (RCTs) in order to calculate the effect size of statin therapy in changing plasma cortisol concentrations. Following a systematic search in Medline, SCOPUS, Web of Science and Google Scholar databases (by up to March 01, 2015), 7 eligible RCTs were selected. Random-effects meta-analysis suggested a significant increase in plasma cortisol concentrations following statin therapy (WMD: 6.34%, 95% CI: 1.80, 10.87, p=0.006). Subgroup analysis confirmed the significance of the effect with lipophilic statins comprising atorvastatin, simvastatin, and lovastatin (WMD: 7.00%, 95% CI: 2.21, 11.79, p=0.004) but not with hydrophilic statins (rosuvastatin and pravastatin) (WMD: 0.60%, 95% CI: -13.46, 14.66, p=0.933). In the meta-regression analysis, changes in plasma cortisol concentrations following statin therapy were found to be independent of treatment duration. Results of this meta-analysis of RCTs suggest a significant elevation in plasma cortisol levels following statin therapy.
References provided by Crossref.org